Crossvault Capital Management’s Merck MRK Stock Holding History

Crossvault Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.61M	Sell	28,625 -150	-0.5%	-$13.3K	1.03%	30
2022 Q1	$2.36M	Buy	28,775 +100	+0.3%	+$7.88K	0.76%	36
2021 Q4	$2.2M	Buy	28,675 +8,620	+43%	+$687K	0.66%	38
2021 Q3	$1.51M	Buy	20,055 +11,365	+131%	+$864K	0.47%	41
2021 Q2	$668K	Buy	8,690 +977	+13%	+$72.7K	0.2%	49
2021 Q1	$567K	Hold	7,713	–	–	0.2%	51
2020 Q4	$602K	Buy	7,713 +812	+12%	+$62.1K	0.22%	44
2020 Q3	$546K	Buy	6,901 +1,572	+29%	+$123K	0.24%	46
2020 Q2	$393K	Hold	5,329	–	–	0.18%	57
2020 Q1	$391K	Sell	5,329 -397	-7%	-$31.2K	0.22%	54
2019 Q4	$497K	Hold	5,726	–	–	0.22%	57
2019 Q3	$460K	Sell	5,726 -53	-0.9%	-$4.25K	0.22%	58
2019 Q2	$462K	Hold	5,779	–	–	0.23%	55
2019 Q1	$459K	Sell	5,779 -2,096	-27%	-$157K	0.24%	56
2018 Q4	$574K	Buy	+7,875	New	+$556K	0.33%	46

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Crossvault Capital Management's MRK Position: Q2 2022 in Review

Crossvault Capital Management reduced its Merck (MRK) stake by 0.52% in Q2 2022, selling an estimated $13.3K and leaving 28,625 shares worth $2.61M. The position accounts for 1.03% of the portfolio, ranked #30.

Crossvault Capital Management first reported a position in MRK in Q4 2018 and has held it in 15 quarters since. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

Crossvault Capital Management held 28,625 shares of Merck worth $2.61M as of Q2 2022.
Crossvault Capital Management sold 150 Merck shares in Q2 2022, an estimated $13.3K.
Merck made up 1.03% of Crossvault Capital Management's portfolio in Q2 2022, its #30 holding.
Crossvault Capital Management first reported a position in Merck in Q4 2018 and has held it in 15 quarters since.
3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Crossvault Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.